MED 6037- Glucose and Ketone Testing at Point of Care

The University Hospitals of North Midlands NHS Trust is conducting a tender process, MED 6037, for glucose and ketone testing at the point of care, relevant to pathology services and reagents. This active procurement is classified under services within the healthcare sector and is located in various regions across the United Kingdom, including UKG23 and UKD6. The procurement follows an open procedure, allowing electronic submissions.

Interested parties should note that the tender period concludes on 18th July 2025, with the enquiries period ending on 4th July 2025. The contract is anticipated to start on 1st April 2026 and could last until 31st March 2031, with potential renewals for two additional twelve-month periods. This tender presents significant business opportunities for companies specialising in medical pathology services and manufacturing reagents.

The contract value is substantial, offering a growth opportunity for businesses capable of delivering high-quality healthcare services and products. The dual emphasis on cost and quality as award criteria suggests that competitive pricing paired with excellent service delivery could be advantageous. Companies with expertise in healthcare diagnostics, particularly those adept at point-of-care testing, would be well-placed to engage in this tender, thereby expanding their operational footprint within the UK's public healthcare sector.